Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU
NCT07064811 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-07-15
Summary
This randomized controlled trial (RCT) with two parallel study arms evaluated the effectiveness of a 24-week exercise intervention in prostate cancer (PCa) patients under-going androgen deprivation therapy (ADT). Ethical approval was obtained from the Clinical Research Ethics Committee of the University Clinical Hospital "Virgen de la Arrixaca" (Murcia, Spain). Participants were randomly assigned to one of two groups: (1) a supervised progressive resistance training program (SPoRT-PCa-ADT), or (2) a control group receiving a home-based exercise protocol following an initial assessment, accom-panied by weekly telephone follow-up. Assessments were conducted at baseline and at 24 weeks to examine changes in physical, functional, and psychosocial outcomes. Addi-tionally, patient-reported outcomes were collected at the 12-week midpoint (Figure 1). This study design enabled the evaluation of both immediate and sustained intervention effects and facilitated a direct comparison between supervised and home-based exercise approaches
Conditions
Interventions
- PROCEDURE
-
Exercise Intervention Protocol
Subjects participated in the supervised exercise program twice weekly (with a 48-72-hour interval between sessions) for 24 weeks, totaling 48 supervised sessions. The progressive resistance training program used velocity-based training principles \[24-26\], a novel approach in exercise oncology that allows for precise load management and indi-vidualization based on daily performance capacity
- PROCEDURE
-
SPoRT-Control Intervention
structured written instructions for a personalized home-based resistance training program. The protocol was designed to prioritize safety, progressive adaptation, and individualization based on each participant's functional capacity and available resources at home. The program was intended to be performed two to three times per week on non-consecutive days, focusing exclusively on lower-body training through a single primary movement. Each session consisted of three effective sets of 12 repetitions, which served as the standard training volume for the main exercise.
Sponsors & Collaborators
-
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
lead OTHER
Principal Investigators
-
Alejandro Soler López · Department of Physical Activity and Sport, Faculty of Sport Science, University of Murcia,
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-15
- Primary Completion
- 2027-02-15
- Completion
- 2027-02-15
Countries
- Spain
Study Locations
More Related Trials
-
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
NCT01607879 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy(ADT)for High Risk Prostate Cancer
NCT05076851 ·Status: UNKNOWN ·Phase: PHASE2
-
Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
NCT05404139 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
NCT04736108 ·Status: UNKNOWN ·Phase: PHASE2
-
Micro RNAs to Predict Response to Androgen Deprivation Therapy
NCT02366494 ·Status: COMPLETED
-
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
NCT05327465 ·Status: RECRUITING ·Phase: NA
-
Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy
NCT01711892 ·Status: COMPLETED ·Phase: NA
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
SRT Versus SRT+ADT in Prostate Cancer
NCT05019846 ·Status: RECRUITING ·Phase: PHASE3
-
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
NCT04869371 ·Status: UNKNOWN ·Phase: PHASE2
-
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
NCT03880422 ·Status: RECRUITING ·Phase: NA
-
PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)
NCT03776045 ·Status: COMPLETED ·Phase: NA
-
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
NCT00388804 ·Status: TERMINATED ·Phase: PHASE3
-
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
NCT04720157 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT06274047 ·Status: RECRUITING ·Phase: PHASE3
-
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562 ·Status: COMPLETED ·Phase: NA
-
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
NCT04248621 ·Status: UNKNOWN ·Phase: PHASE4
-
Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial
NCT03658486 ·Status: COMPLETED ·Phase: NA
-
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
NCT03987217 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
NCT06575257 ·Status: RECRUITING ·Phase: PHASE2
-
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
NCT02440802 ·Status: UNKNOWN
-
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
NCT07163910 ·Status: RECRUITING ·Phase: PHASE2
-
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
NCT06834321 ·Status: RECRUITING ·Phase: PHASE2